Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 694 of 1,261
  1. US 9339482

    Methods to treat dysregulated blood glucose disorders

    Regents of the University of Minnesota · Granted May 17, 2016 · Expires May 12, 2036

    granted
  2. US 9339491

    Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease

    MEREO BIOPHARMA 1 LIMITED · Granted May 17, 2016 · Expires May 12, 2036

    granted
  3. US 9339433

    Methods of diagnosing and treating neonatal reversion to fetal consciousness

    The Regents of the University of California · Granted May 17, 2016 · Expires May 12, 2036

    granted
  4. US 9339469

    R(+)-N-methyl-propargyl-aminoindan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  5. US 9339459

    Particulate materials

    Nektar Therapeutics · Granted May 17, 2016 · Expires May 12, 2036

    granted
  6. US 9339440

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  7. US 9341619

    Hyposialylation disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2016 · Expires May 12, 2036

    granted
  8. US 9341626

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 17, 2016 · Expires May 12, 2036

    granted
  9. US 9340784

    Methods and compositions for modulating alpha-1-antitrypsin expression

    Ionis Pharmaceuticals, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  10. US 9340782

    Antimir-451 for the treatment of polycythemias

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  11. US 9340785

    Selective inhibition of polyglutamine protein expression

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  12. US 9340769

    Methods and compositions for treating P. acnes

    The Regents of the University of California · Granted May 17, 2016 · Expires May 12, 2036

    granted
  13. US 9340612

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  14. US 9340611

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  15. US 9340307

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  16. US 9339515

    Method for treatment of pulmonary fibrosis

    GALECTIN THERAPEUTICS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  17. US 9340777

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  18. US 9340792

    Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses

    Northwestern University · Granted May 17, 2016 · Expires May 12, 2036

    granted
  19. US 9340606

    Immunization with amyloid-beta oligomers

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 17, 2016 · Expires May 12, 2036

    granted
  20. US 9340546

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2016 · Expires May 12, 2036

    granted
  21. US 9340594

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  22. WO 2016071511

    TRAITEMENT DU SYNDROME D'ACTIVATION MASTOCYTAIRE (SAMA) AVEC LE MASINITIB

    AB SCIENCE [FR] · Granted May 12, 2016 · Expires May 7, 2036

    granted
  23. US 2016128999

    MASITINIB FOR TREATING HEPATIC CANCER

    AB SCIENCE [FR] · Granted May 12, 2016 · Expires May 7, 2036

    granted
  24. US 9334522

    Agents and methods to elicit anti-tumor immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.